Illness	Number of cases
Recurrent depressive disorder - Major depressive disorder recurrent severe without psychotic features (F33.2)	1.037
Depressive episode - Major depressive disorder single episode severe without psychotic features (F32.2)	647
Mental and behavioural disorders due to use of alcohol (F10.2)	396
Schizophrenia - Paranoid schizophrenia (F20.0)	376
Recurrent depressive disorder - Major depressive disorder recurrent severe with psychotic symptoms (F33.3)	153
Vascular dementia (F01.3)	133
Borderline personality disorder (F60.31)	101
Alzheimer disease - Alzheimers disease with late onset (G30.1)	59
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances (F19.2)	49
Mental and behavioural disorders due to use of opioids (F11.2)	48

Top 10 treatments

Treatment	Number
(9-649.40)	5.690
Standard treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-607)	5.377
(9-649.0)	5.250
(9-649.50)	3.366
(9-649.10)	3.212
(9-649.31)	3.063
(9-649.11)	1.970
(9-649.51)	1.968
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with one characteristic (9-617)	1.711
(9-649.30)	1.440

Further information about the department

Out-patient accident insurance doctor approval

Yes

In-patient Employers’ Liability Insurance Association approval

Yes

Department key

Department key: 2900

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
8	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies	Es geht um den Nachweis von erwünschten Wirkungen und von Nebenwirkungen eines Medikaments.